Skip to main content
1325 Insight Matters Spring 2025 Hero

Insight Matters report, Spring 2025

19 May 2025 | 20 minutes to read

While navigating uncertainty, perspective is key 

In our latest Insight Matters report, Tony Whincup, Giles Parkinson and Roohi Siddiqui discuss the market events we saw unfold in the first quarter of 2025, what to watch with the ever-evolving US trade tariff situation and investment implications for clients. Our experts, Jon Kirk and James Tulloch, explore the growing obesity drug sector and how the next generation of these drugs might evolve the market.  

You can read a digital version of the report online or download the pdf to read at your leisure, via the links below.

Disclaimer

Past performance is not a reliable indicator of future returns. Nothing herein should be construed as a recommendation to hold, buy or sell any security or encourage any investment decision. The mention of any particular asset class, sub-asset class or company does not imply that it is held, or may ever be held, in any product or service.

 

Before you invest, make sure you feel comfortable with the level of risk you take. Investments aim to grow your money, but they might lose it too.